Abstract
ACETYLCHOLINE (ACh) plays a key role in the transitions between the different phases of sleep1: Slow-wave sleep requires low ACh concentrations in the brain, whereas rapid-eye-movement (REM) sleep is associated with high levels of ACh. Also, these phases of sleep are differentially sensitive to a number of endogenous neuropeptides and cytokines, including somatostatin, which has been shown to increase REM sleep without significantly affecting other phases2. Here we report the cloning and initial characterization of cortistatin, a neuropeptide that exhibits strong structural similarity to somatostatin, although it is the product of a different gene. Administration of cortistatin depresses neuronal electrical activity but, unlike somatostatin, induces low-frequency waves in the cerebral cortex and antagonizes the effects of acetylcholine on hippocampal and cortical measures of excitability. This suggests a mechanism for cortical synchronization related to sleep.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shiromani, P. J., Gillin, J. C. & Henriksen, S. J. A. Rev. Pharmac. Toxicol. 27, 137–56 (1987).
Borbely, A. A. & Tobler, I. Physiol. Rev. 69, 605–670 (1989).
Glushankov, P. et al. Proc. natn. Acacf. Sci. U.S.A. 81, 6662–6666 (1984).
Veber, D. F. et al. Nature 280, 512–514 (1979).
Erlander, M. G. et al. Neuron 7, 91–100 (1991).
Schonbrunn, A. H. & Tashijan, A. J. R., J. biol. Chem. 235, 6473–6483 (1978).
Halliwell, J. V. & Adams, P. R. Brain Res. 250, 71–92 (1982).
Moore, S. D. et al. Science 239, 278–280 (1988).
Schweitzer, P., Madamba, S. & Siggins, G. R. Nature 346, 464–466 (1990).
Andersen, P., Bliss, T. V. P. & Skrede, K. K. Expl Brain Res. 13, 208–221 (1971).
Danguir, J. Brain Res. 367, 26–30 (1986).
Steriade, M., McCormick, D. A. & Sejnowski, T. J. Science 262, 679–685 (1993).
Andersen, P., Eccles, J. C. & Løyning, Y. J. Neurophysiol. 27, 607–619 (1964).
Kandel, E. R. & Spencer, W. A. J. Neurophysiol. 24, 243–259 (1961).
Steffensen, S. & Henriksen, S. J. Brain Res. 538, 46–53 (1991).
Maurer, R. et al. Proc. natn. Acad. Sci. U.S.A. 79, 4815–4817 (1982).
Scharfman, H. E. & Schwartzkroin, P. A. Brain Res. 493, 205–211 (1989).
deLecea, L. et al. Molec. Brain Res. 25, 286–296 (1994).
Schweitzer, P. et al. J. Neurosci. 13, 2033–2049 (1993).
Prospero-Garcia, O., Criado, J. R. & Henriksen, S. J. Pharmac. Biochem. Behav. 49, 413 (1994).
Steffensen, S. C., Campbell, I. L. & Henriksen, S. J. Brain Res. 652, 149 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Lecea, L., Criado, J., Prospero-Garcia, Ó. et al. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381, 242–245 (1996). https://doi.org/10.1038/381242a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/381242a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.